发明名称 PHARMACEUTICAL COMPOSITION
摘要 A pharmaceutical composition for application in human and animals, with at least one systemically and/or locally acting, topically applicable active ingredient and with at least one phospholipid, improving the transport of the active ingredient trough the cell membrane and containing a concentration of at least 60% by weight phosphatidylcholine, referring to the phospholipid, is described. The composition shows such a liquid consistency, that it is able to be sprayed as droplets or as a foam, whereas in the composition such a phospholipid is included, that additionally contains oil in a concentration of maximum 7.5% by weight besides the at least 60% by weight phosphatidylcholine.
申请公布号 US2013309215(A1) 申请公布日期 2013.11.21
申请号 US201213571799 申请日期 2012.08.10
申请人 SEIGFRIED BERND G.;MIKA PHARMA GESELLSCHAFT FUR DIE ENTWICKLUNG UND VERMARKTUNG PHARMAZEUTISCHER PRODUKTE MBH 发明人 SEIGFRIED BERND G.
分类号 A61K47/44;A61K31/192;A61K31/196;A61K31/405;A61K31/454;A61K31/49;A61K31/557;A61K31/56;A61K31/7105;A61K31/711;A61K31/713;A61K36/00;A61K38/43;A61P1/08;A61P1/16;A61P3/02;A61P3/10;A61P5/26;A61P5/28;A61P7/02;A61P7/10;A61P9/00;A61P11/06;A61P11/10;A61P11/14;A61P17/00;A61P17/02;A61P17/04;A61P17/12;A61P21/02;A61P23/02;A61P25/00;A61P25/08;A61P25/16;A61P25/18;A61P25/20;A61P29/00;A61P31/00;A61P31/04;A61P31/10;A61P31/12;A61P33/00;A61P37/02;A61P37/06;A61P37/08 主分类号 A61K47/44
代理机构 代理人
主权项
地址